WHO ICTRP trial
A phase III clinical study to evaluate the immunogenicity and safety of Groups…
ChiCTR2200058396 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2200058396 |
|---|---|
| Public title | A phase III clinical study to evaluate the immunogenicity and safety of Groups ACYW135 Meningococcal Polysaccharide Conjugate Vaccine in healthy subjects aged 6 to 23 months |
| Scientific title | A phase III clinical study to evaluate the immunogenicity and safety of Groups ACYW135 Meningococcal Polysaccharide Conjugate Vaccine in healthy subjects aged 6 to 23 months |
| Primary sponsor | Disease control and prevention center of Hunan Provincial |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 3 |
| Countries | China |
| Conditions | This vaccine is indicated for active immunization to prevent invasive meningococcal diseases caused by N. meningitidis serogroups A, C, Y and W135 |
| Interventions | Study group 1(6-11 months):The investigational vaccine is to be administered at Months 0 and 1 as the primary series and 18 months of age as the booster dose;Control group(6-11 months):The comparator vaccine Group A and C Meningococcal… |
| Registration date | Apr 8, 2022 |
| Target size | Study group 1(6-11 months):300;Control group(6-11 months):300;Study group 2(6-11… |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: